Effects of dietary l-arginine or N-carbamylglutamate supplementation during late gestation of sows on the miR-15b/16, miR-221/222, VEGFA and eNOS expression in umbilical vein by Liu, X. D. et al.
ORIGINAL ARTICLE
Effects of dietary L-arginine or N-carbamylglutamate
supplementation during late gestation of sows on the miR-15b/16,
miR-221/222, VEGFA and eNOS expression in umbilical vein
X. D. Liu • X. Wu • Y. L. Yin • Y. Q. Liu •
M. M. Geng • H. S. Yang • Francois Blachier •
G. Y. Wu
Received: 3 April 2011/Accepted: 4 May 2011/Published online: 3 June 2011
 The Author(s) 2011. This article is published with open access at Springerlink.com
Abstract Placental vascular formation and blood ﬂow are
crucial for fetal survival, growth and development, and
arginine regulates vascular development and function. This
study determined the effects of dietary arginine or N-car-
bamylglutamate (NCG) supplementation during late
gestation of sows on the microRNAs, vascular endothelial
growth factor A (VEGFA) and endothelial nitric oxide
synthase (eNOS) expression in umbilical vein. Twenty-
seven landrace 9 large white sows at day (d) 90 of ges-
tation were assigned randomly to three groups and fed the
following diets: a control diet and the control diet supple-
mented with 1.0% L-arginine or 0.10% NCG. Umbilical
vein of fetuses with body weight around 2.0 kg (oversized),
1.5 kg (normal) and 0.6 kg (intrauterine growth restriction,
IUGR) were obtained immediately after farrowing for
miR-15b, miR-16, miR-221, miR-222, VEGFA and eNOS
real-time PCR analysis. Compared with the control
diets, dietary Arg or NCG supplementation enhanced the
reproductive performance of sows, signiﬁcantly increased
(P\0.05) plasma arginine and decreased plasma VEGF
and eNOS (P\0.05). The miR-15b expression in the
umbilical vein was higher (P\0.05) in the NCG-supple-
mented group than in the control group. There was a trend
in that the miR-222 expression in the umbilical vein of the
oversized fetuses was higher (0.05\P\0.1) than in the
normal and IUGR fetuses. The expression of eNOS in both
Arg-supplemented and NCG-supplemented group were
lower (P\0.05) than in the control group. The expression
of VEGFA was higher (P\0.05) in the NCG-supple-
mented group than in the Arg-supplemented and the con-
trol group. Meanwhile, the expression of VEGFA of the
oversized fetuses was higher (P\0.05) than the normal
and IUGR fetuses. In conclusion, this study demonstrated
that dietary Arg or NCG supplementation may affect
microRNAs (miR-15b, miR-222) targeting VEGFA and
eNOS gene expressions in umbilical vein, so as to regulate
the function and volume of the umbilical vein, provide
more nutrients and oxygen from the maternal to the fetus
tissue for fetal development and survival, and enhance the
reproductive performance of sows.
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High embryonic loss and fetal deaths during gestation
limited the number of piglets born at farrowing in sows
(Pope 1994; Mateo et al. 2007). Higher fetal growth rates
may require an increased provision of nutrients for sup-
porting the metabolic needs of both the sow and her fetuses
(Wu et al. 2004; Kim et al. 2005). Adequate vasculogenesis
and angiogenesis of the maternal vasculature is important
for providing adequate maternal oxygen/nutrients and
blood ﬂow to the placenta. Placental angiogenesis supports
the required blood ﬂow on the fetal side necessary for fetal
growth and development. Therefore, vasculogenesis and
angiogenesis are essential for proper placental develop-
ment (Wu et al. 2004; Demir et al. 2007; Arroyo and Winn
2008). Umbilical venous blood ﬂow is crucial for fetal
growth and development (Barbera et al. 1999; Ferrazzi
et al. 2000; Boiti et al. 2002).
The vascular endothelial growth factor (VEGF) proteins
are mostly known to regulate the processes of vasculogen-
esis and angiogenesis (Hanahan 1997; Otrock et al. 2007;
Demir et al. 2007; Arroyo and Winn 2008; Yao et al. 2011).
As a potent endothelial survival factor, VEGF induces
vasodilation and facilitates blood ﬂow by increasing nitric
oxide (NO) production (Hood et al. 1998; Otrock et al.
2007). MicroRNAs (miRNAs), about 22-nucleotide, non-
coding RNAs, have been shown to be involved in various
biological processes in animals (Ambros 2004; Kloos-
terman and Plasterk 2006), including angiogenesis regula-
tion (Kuehbacher et al. 2008; Anand et al. 2010). Recently,
it is reported that miR-15b, miR-16, miR-221 and miR-222
target VEGFA (Hua et al. 2006; Karaa et al. 2009) and
eNOS (Poliseno et al. 2006;S u a ´rez et al. 2007) expressions
in angiogenesis.
Arginine (Arg) can enhance the reproductive performance
of pigs (Mateo et al. 2007;W ue ta l .2007) and also regulate
angiogenesis (Raghavan and Dikshit 2004). In addition,
N-carbamylglutamate (NCG) increases the endogenous syn-
thesis of Arg (Frank et al. 2007;W ue ta l .2010).
Therefore, we hypothesized that dietary supplementation
withArgorNCGmayenhancethe reproductiveperformance
of sows and the potential mechanisms are that microNRAs
(miR-15b, miR-16, miR-221 and miR-222) target VEGFA
and eNOS gene expression in fetal umbilical vein so as to
regulate the function and volume of the umbilical vein,
thereby providing more nutrients and oxygen from the
maternaltothefetustissueforfetaldevelopmentandsurvival.
Materials and methods
This study was performed in accordance with the Chinese
guidelines for animal welfare and approved by the Animal
Care and Use Committee of the Institute of Subtropical
Agriculture, the Chinese Academy of Sciences (Yin et al.
1993).
Animals and experimental design
A total of 27 Large White 9 Landrace crossbred sows at d
90 of gestation with initial body weight (BW) of
187 ± 5 kg, parity of 3.2 ± 0.7 and similar reproductive
performance at last parity were chosen and assigned to
three groups randomly: a control group (fed a corn- and
soybean meal-based diet) and two treatment groups (fed a
corn- and soybean meal-based diet supplemented with
1.0% L-Arg HCl (Arg) or 0.1% NCG) (Table 1). L-Arg HCl
was obtained from Ajinomoto Inc. (Tokyo, Japan) and
NCG was provided by the Institute of Subtropical Agri-
culture, the Chinese Academy of Sciences.
ThedoseofArgwas based onpreviousstudy(Mateoetal.
2007), and the dose of NCG was based on our own study.
The sows were housed individually in gestation crates
(2.0 9 0.6 m, concrete ﬂoor) and transferred to individual
farrowing crates (2.2 9 1.5 m) at d 107 of gestation. The
sows were provided 2 kg diet (on an as-fed basis) daily as
two equal-sized meals (08:00 and 16:30 h) during the
entire gestation period. All the diets provided 13.5 MJ
metabolizable energy/kg and 14.7 crude protein (on as-fed
basis). All the sows had free access to drinking water.
Sample collection
Blood samples were collected 2 h after feeding via jugular
venepuncture into heparinized tubes on d 110 of gestation.
Samples were centrifuged at 2,0009g, 15 min at 4C
(Mateo et al. 2007; Yin et al. 2010). Plasma was transferred
to 1.5 microcentrifuge tubes and stored at -20C until
analysis (Geng et al. 2011). The total number of piglets and
their BW at birth were recorded. The piglets were classiﬁed
as born alive or dead as previously described (Mateo et al.
2007). The number of mummiﬁed fetuses (early or middle
gestation deaths) was neglected.
The umbilical veins of piglets with BW of about 2.0 kg
(oversized), 1.5 kg (normal) and 0.6 kg (IUGR) were
obtained immediately after farrowing. Samples were of
length about 5 cm, 10 cm from the body, and washed with
4C PBS (RNA free). Then the samples were collected into
1.5 microcentrifuge tubes (RNA free) with RNAlater
(Applied Biosystems, Valencia, CA, USA) in it and stored
at -20C for RT-PCR analyses (Wu et al. 2010).
Chemical analyses
Plasma samples were assayed for biochemical indices
using Beckman Coulter CX4 Pro. (Beckman, USA),
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123standards obtained from Beckman (Beckman, USA) (Tang
et al. 2005). Plasma concentrations of free amino acids
were analyzed by Amino Acid Analyzer, Hitachi L8800
(Hitachi, Japan), and amino acid standards were obtained
from Sigma Chemical (Kong et al. 2009). Plasma con-
centrations of VEGF and eNOS were analyzed using
enzyme-linked immunosorbent assay (ELISA) from R & D
system (Minneapolis, MN, USA) and an ELISA plate
reader (BioTek, USA) (Deng et al. 2010). Concentrations
of hormones were analyzed by radioimmunoassay (Jiuding,
China).
Real-time PCR analyses
RT-PCR for VEGFA and eNOS in fetal umbilical vein
Total RNA was isolated by Trizol (Invitrogen, USA, Karaa
et al. 2009) and treated with DNase. Reverse transcription
was performed using AMV Reverse Transcriptase Kit
(Promega, USA). mRNA levels for VEGFA and eNOS
were determined by a standard real-time polymerase chain
reaction (RT-PCR) method. RT-PCR was performed with
the total RNA using TaKaRa one-step RNA PCR Kit
(TaKaRa Bio Inc, Japan). The primer pairs for VEGFA,
eNOS and GAPDH are presented in Table 2. GAPDH was
used as the housekeeping gene, whose mRNA levels in the
fetal umbilical vein did not differ among the groups. The
RT-PCR conditions were: 10 min pre-denaturation at
95C, and then 15 s denaturation at 94C, and 30 s
annealing at 60C for 40 cycles. The relative quantiﬁcation
of gene ampliﬁcation by RT-PCR was performed using
cycle threshold (CT) values. The comparative CT value
method was employed to quantitate expression levels for
VEGFA and eNOS relative to those for GAPDH. The ﬁnal
PCR product was visualized in a 2% agarose gel.
RT-PCR for miR-15b, miR-16, miR-221 and miR-222
Expression of mature miRNAs was measured using mi-
Script PCR System (Qiagen, Hilden, Germany) (Chen et al.
Table 1 Composition of
gestation diets, on an as-fed
basis (%)
a The premix provided the
following per kg of diet: Fe
(FeSO4 H2O) 80 mg, Mn
(MnSO4 5H2O) 45 mg, Zn
(ZnO) 100 mg, Cu
(CuSO4 5H2O) 20 mg, I (KI)
0.70 mg, Se (Na2SeO3 H2O)
0.25 mg, vitamin A 10,000 IU,
vitamin D3 2,500 IU, vitamin E
100 IU, vitamin K 10 IU,
vitamin B2 10 mg, vitamin B6
1 mg, vitamin B12 50 lg, biotin
80 lg, folic acid 5 mg, nicotinic
acid 15 mg, choline chloride
1,500 mg
Item Treatment
Control Arg NCG
Ingredient
Corn 70.30 70.30 70.30
Soybean meal 12.00 12.00 12.00
Wheat middling 4.00 3.00 3.90
Rice bran meal 3.00 3.00 3.00
Puffed soybean 3.00 3.00 3.00
Salt 0.35 0.35 0.35
Potassium chloride 0.75 0.75 0.75
Vitamin–mineral premix
a 3.00 3.00 3.00
Dicalcium phosphate 2.20 2.20 2.20
Limestone 0.50 0.50 0.50
Soy oil 0.50 0.50 0.50
Mold-inhibitor 0.09 0.09 0.09
L-Lys HCl 0.20 0.20 0.20
DL-Met 0.06 0.06 0.06
L-Thr 0.05 0.05 0.05
L-Arginine HCl – 1.00 –
NCG – – 0.10
Nutrient composition
DM (%) 88.2 88.2 88.2
ME (MJ/kg) 13.5 13.5 13.5
CP (%) 14.7 14.7 14.7
Lys (%) 0.78 0.78 0.78
Met ? Cys (%) 0.69 0.69 0.69
Ca (%) 0.92 0.92 0.92
Total P (%) 0.67 0.67 0.67
Available P (%) 0.45 0.45 0.45
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1232005). The miScript PCR System comprises the following
components: miScript Reverse Transcription Kit, miScript
SYBR Green PCR Kit, miScript Primer Assay.
Total RNA was extracted as described above. After
cDNA synthesis, the cDNA serves as the template for real-
time PCR analysis using a miScript Primer Assay in
combination with the miScript SYBR Green PCR Kit.
Mature miRNAs are ampliﬁed using the miScript Universal
Primer together with the miRNA-speciﬁc primer (the
miScript Primer Assay). Primers for sus scrofa miR-15b,
miR-16, miR-221 and miR-222 (miRBase, http://www.
mirbase.org) were designed by Qiagen. 5S rRNA (forward
primer: 50-gcccgatctcgtctgatct-30, reverse primer: 50-agcct
acagcacccggtatt-30) was used as the referent for miRNAs
expression for its constant expression level across all
samples and suitable size. The ampliﬁcation protocol was
as follows: 95C for 5 min, 50 cycles of denaturation
at 94C/15 s, annealing temperature of 55C/30 s, and
extension at 70C/30 s. Real-time analysis of PCR ampli-
ﬁcation was performed on an Applied Biosystems 7900HT
Sequence Detection System and analyzed with an SDS 2.3
Software (Applied Biosystems).
The ﬁnal PCR product was visualized in a 2% agarose
gel. All the procedures above followed the instructions of
each manufacturer.
Statistical analyses
The relative quantiﬁcation of gene ampliﬁcation by
RT-PCR was performed using cycle threshold (CT) values.
The comparative CT value method was employed to
quantitate expression levels for VEGFA and eNOS relative
to those for GAPDH. The DDCT method is used for relative
quantiﬁcation when working with the miScript PCR
System. This comparative method relies on comparing the
differences in CT values obtained with normal versus
experimental samples. The threshold cycle (CT) obtained
with the miScript PCR Control (5S rRNA) is used to
normalize the data.
Values are presented as the mean ± SEM. Data of gene
and miRNAs expression were analyzed using the GLM and
the others using the one-way ANOVA (SAS 9.1.3, SAS
Inc., USA). In case of a P value\0.05, the result was
regarded as statistically signiﬁcant, while 0.05 B P\0.1
was considered as a trend.
Results
Gestation performance
The reproductive performance of sows fed diets supple-
mented with Arg or NCG can be seen in Table 3. The total
number of piglets born, birth weight of all piglets born or
born alive, and litter birth weight of all piglets born did not
differ between the three groups of sows. However, there
was a trend (0.05\P\0.1) toward an increase in the
number of piglets born alive for sows fed the Arg or NCG-
supplemented diet compared with sows fed the control diet.
The litter birth weight of all piglets born alive were
15% higher (P\0.05) for Arg-supplemented sows and
14% (P\0.05) higher for NCG-supplemented sows, both
Table 2 Primers for VEGFA,
eNOS and GAPDH
F forward, R reverse
Target gene Primer sequences Products Annealing
temperature (C)
VEGFA F: CAACGACGAAGGTCTGGAGTG 155 60
R: GCCTCGCTCTATCTTTCTTTGG
eNOS F: ACGCCCGTCTTCCACCA 193 60
R: ACGCCTTCACTCGCTTCG
GAPDH F: GTGCTGAGTATGTCGTGGAGTC 196 60
R: CAGTTGGTGGTACAGGAGGC
Table 3 Reproductive
performance of sows
In the same row, values with
different letter mean signiﬁcant
difference (P\0.05)
Items Control Arg NCG SEM
Total piglets born per litter (n) 11.22 11.38 11.33 0.26
Total piglets born alive per litter (n) 9.78 10.87 10.77 0.24
Birth weight of all piglets born (kg) 1.44 1.50 1.49 0.02
Birth weight of all piglets born alive (kg) 1.45 1.51 1.49 0.02
Litter birth weight of all piglets born (kg) 16.09 16.87 16.83 0.25
Litter birth weight of all piglets born alive (kg) 14.12b 16.26a 16.04a 0.29
Piglets born dead per litter (n) 1.44a 0.50b 0.56b 0.14
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123compared with the control group. The number of piglets
born dead were 65% lower (P\0.05) for the Arg-sup-
plemented sows and 61% lower (P\0.05) for the NCG-
supplemented sows, both compared with the control group.
The days from weaning to estrus of sows did not differ
between the three groups (data not shown).
Plasma biochemical assays
Concentrations of glucose, ammonia, albumin, total pro-
tein, Ca
2?,C u
2? and Mg
2? in plasma did not differ
between the three groups (Table 4). Concentrations of
phosphorus and Zn
2? were both higher (P\0.05) in Arg
or NCG -supplemented sows than in the control group of
sows (Table 4). There was a trend (0.05\P\0.1) toward
the decrease in the concentrations of urea nitrogen for Arg-
supplemented sows compared with the control group of
sows.
Plasma-free amino acids concentration
Concentrations of the most measured free amino acids in
plasma did not differ among the three groups of sows at d
110 of gestation. Compared with the control group, dietary
supplementation with Arg (P\0.01) or NCG (P\0.05)
increased the concentrations of arginine in the plasma of
sows (Fig. 1). Compared with the control diet and Arg-
supplemented diet, NCG increased (P\0.05) the con-
centrations of aspartate in the plasma of sows and
decreased (P\0.05) the concentrations of proline (Fig. 1).
Plasma hormone concentrations
Concentrations of estriol and progesterone did not differ
among the three groups (Table 5). Plasma growth hormone
in Arg or NCG-supplemented sows were higher (P\0.05)
compared with sows fed the control diets. Concentrations
of estradiol were lower (P\0.05) in NCG-supplemented
sows than in the other two groups. In addition, there was a
trend (0.05\P\0.1) for sows fed the NCG-supple-
mented diet to have increased hormone concentrations of
insulin-like growth facter-1 compared with sows in the
control group.
Plasma concentrations of VEGF and eNOS
Protein concentrations of VEGF in plasma were 11 and
10% lower in Arg-supplemented sows (P\0.05) and
NCG-supplemented sows (P\0.05) than in the control
group of sows, respectively (Table 6). Protein concentra-
tions of eNOS were 17 and 23% lower in Arg-supple-
mented sows (P\0.05) and NCG-supplemented sows
(P\0.01) than in the control group of sows (Table 6).
VEGFA and eNOS gene expression
The expression of eNOS in both Arg-supplemented and
NCG-supplemented group was lower (P\0.05) than in
the control group (Fig. 2). The expression of VEGFA was
higher (P\0.05) in the NCG-supplemented group than in
Table 4 Plasma biochemical
indices
In the same row, values with
different letter mean signiﬁcant
difference (P\0.05)
Items Control Arg NCG SEM
Glucose (mmol/L) 3.51 3.77 3.89 0.14
Ammonia (lmol/L) 85.42 85.09 85.73 0.16
Urea nitrogen (mmol/L) 5.83 5.19 5.41 0.14
Albumin (g/L) 26.29 28.03 26.87 0.61
Total protein (g/L) 62.09 65.96 67.12 1.59
Phosphorus (mmol/L) 1.52a 1.74b 1.76b 0.04
Ca
2? (mmol/L) 2.09 2.28 2.19 0.05
Cu
2? (lmol/L) 33.84 32.40 32.22 0.79
Mg
2? (mmol/L) 1.73 1.71 1.65 0.20
Zn
2? (mmol/L) 3.12a 4.94b 4.27b 0.26
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Fig. 1 Concentrations of free amino acids in plasma (lmol/L). For
the same grayscale of the bar, values with different letter mean
signiﬁcant difference (P\0.05), the same as given below
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Meanwhile, the expression of VEGFA of the oversized
fetuses was higher (P\0.05) than the normal and IUGR
fetuses (Fig. 3). There was no effect of the diet 9 BW
interaction on VEGFA and eNOS gene expression.
MiR-15b, miR-16, miR-221 and miR-222 expression
The miR-15b expression in the umbilical vein was higher
(P\0.05) in the NCG-supplemented group than in the
control group (Fig. 4). There was a trend toward the miR-
222 expression in the umbilical vein of the oversized
fetuses being higher (0.05\P\0.1) than the normal and
IUGR fetuses (Fig. 5). There was no effect of diet 9 BW
interaction on these miRNAs expression.
Table 5 Concentration of
hormones in plasma
In the same row, values with
different letter mean signiﬁcant
difference (P\0.05)
Items Control Arg NCG SEM
Insulin (lg/dl) 37.92 40.53 35.97 2.46
Growth hormone (ng/ml) 1.21a 1.70b 1.68b 0.10
Insulin-like growth factor-1 (ng/ml) 30.52 43.68 46.22 3.91
Estradiol (pg/ml) 135.72b 138.44b 67.02a 13.60
Estriol (pg/ml) 4.38 4.98 4.21 0.66
Progesterone (ng/ml) 2.74 2.48 2.11 0.18
Table 6 Plasma concentration of VEGF and eNOS
Items Control Arg NCG SEM
VEGF (mg/L) 177.38a 158.03b 159.57b 3.85
eNOS (U/L) 10.61a 8.78b 8.15b 0.37
In the same row, values with different letter mean signiﬁcant difference (P\0.05)
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Fig. 2 Effects of Arg and NCG on the VEGFA and eNOS gene
expression levels in the umbilical vein
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Fig. 3 Effects of body weight on the VEGFA and eNOS gene
expression levels in the umbilical vein
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Fig. 4 Effects of Arg and NCG on the miR-15b, 16, 221 and 222
expression levels in the umbilical vein
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Maternal nutrition and oxygen play a key role in regulating
fetal survival, growth and development (Wu et al. 2004).
Malnutrition is known to be a major cause of pregnancy
complications, such as intrauterine growth restriction
(IUGR) or even worse, such as embryonic loss and fetal
deaths during gestation. Thus, providing the pregnant dam
with proper nutrition is vital for the fetus (Snoeck et al.
1990; Hoet and Hanson 1999; McPherson et al. 2004).
Various evidences have substantiated the importance of
arginine in the survival, growth, and development of fetal
pigs (Wu et al. 2004, 2007). Furthermore, amino acid
malnutrition in gestating sows results in lower concentra-
tions of arginine in the placenta and fetal plasma (Wu et al.
1998), as well as reduced the synthesis of NO (the endo-
thelium-derived relaxing factor) from L-arginine (Wu et al.
2009) and the synthesis of polyamines (Pegg 1986).
Impaired placental synthesis of both NO and polyamines is
considered a major factor contributing to IUGR (Wu et al.
2004, 2006). Additionally, previous studies showed that
uterine uptake of arginine may not be sufﬁcient to meet
fetal growth requirements during late gestation in pigs (Wu
et al. 1999). NCG is a safe and metabolically stable analog
of NAG (Wu et al. 2009; Gessler et al. 2010) and increases
the endogenous synthesis of Arg (Frank et al. 2007;W u
et al. 2009).
The results of this study showed that Arg or NCG
supplementation to gestation diets for late pregnant sows
improved pregnancy outcome, decreased plasma urea
concentrations and increased the plasma concentrations of
free arginine of sows at d 110 of gestation. Mateo et al.
(2007) also reported the similar results. This suggested that
both Arg and NCG supplementation provided better
nutrients to sows, and therefore probably improved the
uterine environment for fetal growth and development.
Additionally, arginine is not only required for protein
synthesis and ammonia detoxiﬁcation, but is also a pre-
cursor of many metabolically important molecules,
including proline, ornithine, polyamines and NO (Wu and
Morris 1998; Kim et al. 2007).
However, proper nutrition for sows cannot guarantee
good reproductive efﬁciency. The placenta is responsible
for the exchange of nutrients and oxygen from the mother
to the fetus. Adequate vasculogenesis and angiogenesis of
the maternal vasculature are important for providing ade-
quate maternal nutrients/oxygen and blood ﬂow to the
placenta. Placental vascular formation and function are
important for fetal growth and development. Proper
development of the placenta is critical for a successful
pregnancy, mediates important steps, such as maternal
blood ﬂow to the placenta and delivery of nutrients to the
fetus, and ensures the exchange of nutrients/oxygen and
blood ﬂow necessary for fetal growth (Arroyo and Winn
2008).
Also, umbilical venous blood ﬂow is crucial for fetal
growth and development (Barbera et al. 1999; Ferrazzi
et al. 2000; Boiti et al. 2002). Pathologic umbilical vein
leads to pregnancy complications too (Klaritsch et al. 2008;
Koech et al. 2008). Vascular growth is necessary to
increase placental fetal blood ﬂow over gestation. Poor
vascular development is known to cause intrauterine
embryonic death characterized by low vascular density in
the placental villi along with ﬁbrosis and other deﬁciencies.
The VEGF proteins are the most studied family of growth
factors known to regulate the processes of vasculogenesis
and angiogenesis. VEGFA (also known as VEGF), aside
from being a potent endothelial survival factor, is also
known to induce vasodilation by increasing nitric oxide
(NO) production, another function which facilitates blood
ﬂow. ENOS is critical in the regulation of vascular function
(Lu et al. 2011) and can generate both nitric oxide (NO)
and superoxide (O2
-), which are key mediators of cellular
signaling (Chen et al. 2010).
MicroRNAs (miRNAs), about 22-nucleotide, non-cod-
ing RNAs, have come into focus as a powerful mechanism
to regulate angiogenesis (Dews et al. 2006; Urbich et al.
2008). It has been demonstrated that miR-221 and miR-222
block endothelial cell migration, proliferation and angio-
genesis and indirectly regulate the expression of endothe-
lial nitric oxide synthase (Poliseno et al. 2006). In addition,
miR-221 and miR-222 inhibit cell proliferation and reduce
the expression of c-Kit in hematopoietic progenitor cells—
a process that can contribute to vessel growth (Kuehbacher
2007). Two other miRNAs that might be involved in
angiogenesis are miR-15b and miR-16. MiR-15b and miR-
16 have been shown to control the expression of VEGF
(Hua et al. 2006). Data indicate that hypoxia-induced
reduction of miR-15b and miR-16 contributes to an
increase in VEGF. Some other miRNAs also regulate
angiogenesis and vascular function (Anand et al. 2010).
In this study, the levels of gene expression of VEGFA
and eNOS in umbilical vein and decrease in the plasma
concentrations of VEGFA and eNOS in both the Arg- and
NCG-supplemented groups may be a feedback regulatory
mechanism of arginine-produced NO in the fetal umbilical
vein and placenta compared with the control group. This is
supported by high expression of miR-15b and miR-222 in
the umbilical vein of dietary Arg- or NCG-supplemented
groups.
The arginine treatment may enhance placental angio-
genesis and growth during early-to mid-gestation, thereby
promoting an optimal intrauterine environment throughout
pregnancy (Wu et al. 2004). Therefore, it is possible that
dietary supplementation with arginine increases the syn-
thesis of NO in the placenta and fetus, as reported for adult
Effects of dietary L-arginine or NCG supplementation during late gestation 2117
123rats (Wu and Morris 1998; Kohli et al. 2004). The outcome
would be to enhance placental angiogenesis and growth
(including vascular growth), utero-placental blood ﬂow, the
transfer of nutrients from mother to fetus, and, therefore,
fetal survival, growth and development (Kwon et al. 2004;
Wu et al. 2004, 2006).
Although the majority of the conceptus loss occurs
during the peri-implantation period, there is evidence that
signiﬁcant losses also occur during later gestation (Wilson
2002). Piglets born dead per litter were signiﬁcantly
decreased both in Arg-supplemented and NCG-supple-
mented groups in this study, which is similar to the study
reported previously (Mateo et al. 2007). This may suggest
that dietary Arg or NCG supplementation also regulated
placenta vascular functions.
Notably, we found that plasma concentrations of phos-
phorus and Zn
2? were higher both in sows of the Arg-sup-
plemented and NCG-supplemented groups, indicating that
Arg or NCG supplementation increases protein synthesis of
fetus (Castillo-Dura ´n and Weisstaub 2003; Frank et al.
2007). This is in agreement with the ﬁndings reported pre-
viously (Mateo et al. 2007). This study showed that dietary
Arg or NCG supplementation increased litter piglets born
alive and litter birth weight of all piglets born alive, while
there were not differences in the average birth weights of all
piglets born or of piglets born alive between groups. Fur-
thermore, plasma concentrations of growth hormone were
higher in sows of Arg-supplemented and NCG-supple-
mented groups than in sows of the control group.
In summary, supplementing dietary Arg or NCG during
late gestation enhanced the reproductive performance of
sows. Also, Arg or NCG treatment improved efﬁciency in
the utilization of dietary nutrients; we propose that Arg or
NCG treatment may effect the expression of miRNA-15b
and miRNA-222, thereby controlling its target, VEGFA
and eNOS, respectively, gene expression in the umbilical
vein. Thus, Arg may regulate angiogenesis and vascular
development and functions of umbilical vein and placenta,
providing more nutrients and oxygen from mother to
fetuses for fetal survival, growth and development. How-
ever, it is necessary to determine how arginine regulate
fetal survival, growth and development through
microRNAs.
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